Canna Law Blog

AUGUST 25, 2020

The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. The drug caught DEA’s attention when recreational use proliferated. Fortunately, by criminalizing MDMA, DEA was able to stamp out its use entirely, as it did with cannabis and other hazardous schedule I drugs.

DEA 88

DEA Therapy Decriminalization Pharmaceutical 88

Canna Law Blog

AUGUST 25, 2020

The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. The drug caught DEA’s attention when recreational use proliferated. Fortunately, by criminalizing MDMA, DEA was able to stamp out its use entirely, as it did with cannabis and other hazardous schedule I drugs.

DEA 84

DEA Therapy Decriminalization Pharmaceutical 84

Cannabis Law Report

JANUARY 19, 2022

The US Food and Drug Administration (FDA) and potentially the Drug Enforcement Agency (DEA), could bring enforcement action against producers of some of these intoxicating products if they so choose. Safety concerns. However THCP, an intoxicating cannabinoid discovered in 2019, is too novel to fully establish its legal status.

Hemp 52

Hemp DEA Cannabinoids Topical 52

Veriheal

JUNE 30, 2023

FDA Drops Psychedelic Research Guide The Food and Drug Administration (FDA) has released draft guidance outlining the unique considerations researchers should keep in mind when studying psychedelics. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

SpeedWeed

MARCH 11, 2021

Back in August 2020, the Drug Enforcement Administration (the “DEA”) released its Interim Final Rule (the “ IFR” ) in which the agency stated, in part, that “[a]ll synthetically derived tetrahydrocannabinols remain schedule I controlled substances.” This chemical conversion is at the root of the legal confusion. State Legal Frameworks.

THC 52

THC Business DEA Cannabinoids 52

Cannabis Law Report

AUGUST 23, 2021

The 2018 Farm Bill did not change anything with respect to animal food. Hemp or any derivatives remain Unapproved Ingredients for use in animal food of any kind or any species. New animal drugs, as well as new animal food products, are subject to pre-market approval for specific species.

Pets 105

Pets Hemp CBD Food 105

Veriheal

APRIL 11, 2022

Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb. federal law.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 30, 2021

Food and Drug Administration (FDA) and the Alcohol and Tobacco Tax and Trade Bureau (TTB). The FDA is currently in an ongoing process evaluating the science and safety of CBD and hemp derivatives in order to determine potential regulatory pathways for hemp.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

JUNE 6, 2019

In July 2018, CDPH issued an FAQ asserting the agency’s position, consistent with the FDA, that hemp-derived CBD is not an approved food ingredient, food additive, or dietary supplement. That said, to ensure consumer safety, CDPH needs regulatory authority over processors of hemp like all other food manufacturers.

Hemp 66

Hemp Legislation Food Consumption 66

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] DEA and the Controlled Substances Act. Stacy Cline Amin. Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 28, 2022

Food and Drug Administration (FDA) to regulate hemp derived cannabinoids such as CBD continues to negatively impact the industry. Department of Agriculture (USDA) acted timely in establishing rules for production, the inaction of the U.S. Farmers are not the only ones who are being crushed by this regulatory uncertainty.

Agriculture 52

Agriculture Hemp CBD Research and Development 52

FloridaMarijuana.net

JULY 8, 2018

According to the MAPS website they are “working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs).

Strains 190

Strains Indica Hybrid Research and Development 190

SpeedWeed

APRIL 27, 2021

“But my contacts at the American Herbal Products Association, as well as the DEA (Drug Enforcement Administration) and the American Western Hemp Professionals, and the U.S. Anecdotally, we understand that the DEA is actively monitoring the proliferation of delta-8 THC products.”. Andrea Golan, cannabis industry lawyer.

Legalization 52

Legalization DEA Supply Chain Hemp 52

Cannabis Law Report

FEBRUARY 25, 2019

New York represents one high-profile example where, somewhat surprisingly, the New York City Department of Health seized products featuring CBD as a food additive from restaurants, bars, bakeries, and coffee shops. In fact, the 2018 Farm Bill did not impact the FDA’s oversight authority as to hemp-derived products.

CBD 71

CBD Food Compliance Compliance 71

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

MAY 25, 2022

The court also considered Boyd Street’s counterarguments that (1) DEA has interpreted the 2018 Farm Bill as inapplicable to delta-8 THC due to its method of manufacture and (2) Congress never intended for the Act to legalize any psychoactive substance. as opposed to delta-8 THC or total THC (i.e.,

THC 52

THC Legalization Hemp Concentrates 52

SpeedWeed

MAY 26, 2021

It’s often dabbed or vaped, but it can also be infused in foods to create delta-8 edibles. Last year, the US Drug Enforcement Administration (DEA) claimed that delta-8, like delta-9, was federally banned. Delta-8 manufacturers have used this fact to justify that their products are legal. .

THC 52

THC Hemp Cannabinoids CBD 52

Cannabis Law Report

APRIL 21, 2022

MDMA is a promising psychedelic compound, currently placed by the Drug Enforcement Administration (DEA) in Schedule I of the Controlled Substances Act, that has been produced for legal research in small batches by certified laboratories. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

SpeedWeed

JUNE 8, 2021

Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S.

Topical 40

Topical THC Cannabinoids Agriculture 40

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. To achieve this, two things need to happen.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 112

Research and Development DEA Marijuana Pharmaceutical 112

SpeedWeed

MARCH 18, 2021

Wasn’t the DEA going to let others grow research-grade cannabis? Higher quality cannabis flower suitable for Food and Drug Administration (FDA) approval is currently unavailable domestically due to restrictions on production imposed by the U.S. When the research team tested the cannabis sent by NIDA, even the 12% strain came up short.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

APRIL 14, 2022

Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. Manufacturing operations generate waste similar to non-cannabis businesses that produce similar products, such as food and tinctures.

Environment 52

Environment Agriculture Compliance Compliance 52

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

MAY 17, 2019

Food and Drug Administration (“FDA”) simultaneously charged three cannabidiol (“CBD”) companies with violating the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 Powered by a $6.1

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.” Table of Contents. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Sensi Seeds

NOVEMBER 28, 2018

There are further laws, some of which apply to the presentation and sale of cannabis products, in particular, CBD oil for human consumption as a food supplement, but they’ve been overlooked until now. Considering Europe’s Food and Drinks Industry is the biggest manufacturing employer in the Single Market, with an annual turnover of €1.1

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Canna Law Blog

MARCH 4, 2020

Food and Drug Administration (FDA) to cities and counties. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. This post is dedicated to clearing up some of the confusion behind ketamine clinic set-up and operation.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

JUNE 8, 2021

Hemp Acres has built 3 facilities specialized for each hemp commodity, totaling 40,000 sq ft of food grade hemp processing facilities, designed to handle 50,000 acres of contracted hemp throughout the midwest for grain, fiber, and botanical extracts. Cannabis-infused food and beverages could reshape the industry.

Hemp 102

Hemp Seed-To-Sale Food Research and Development 102

Cannabis Law Report

JULY 27, 2022

Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S. As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision.

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Canna Law Blog

OCTOBER 26, 2020

The Vertical Bliss case is one of the first massive enforcement actions since the implementation of licensing under the Medical and Adult-Use Cannabis Regulation and Safety Act–late last year, the California Department of Food and Agriculture sued another operator, but not much public enforcement has happened since then.

Compliance 79

Compliance Compliance DEA Business 79

Canna Law Blog

MARCH 4, 2020

Food and Drug Administration (FDA) to cities and counties. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. This post is dedicated to clearing up some of the confusion behind ketamine clinic set-up and operation.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

JUNE 1, 2021

Martha Stewart CBD products are already a top 9 brand among all CBD supplements in the food, drug and convenience-store channel, according to IRI data for the 4 weeks ended April 18, 2021. Food and Drug Administration (the “FDA”), the U.S. Drug Enforcement Administration (the “DEA”), the U.S.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

MAY 24, 2022

Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions. Many substances regulated under the CSA are also subject to other federal or state regulations, including the Federal Food, Drug, and Cosmetic Act (FD&C Act).

DEA 52

DEA History Medicine Marijuana 52